Word

COMBIMASC

Status

Dead

Status Code

602

Status Date

Sunday, March 9, 2003

Serial Number

75913519

Mark Type

5000

Filing Date

Wednesday, February 9, 2000

Abandoned Date

Friday, January 17, 2003

Trademark Owner History

PolyMASC Pharmaceuticals Plc

Classifications

1 POLYMER DERIVATIVES AND POLYETHYLENE GLYCOLDERIVATIVES FOR USE IN THE MANUFACTURE OF THERAPEUTIC AND DIAGNOSTIC AGENTS AND IMAGING AGENTS FOR DIAGNOSTIC PURPOSES; POLYMER DERIVATIVES AND POLYETHYLENE GLYCOLDERIVATIVES FOR USE IN THE MANUFACTURE OF COSMETIC AND PHARMACEUTICAL PREPARATIONS AND SUBSTANCES; POLYMERBEADS FOR USE IN MANUFACTURING; POLYALKYLENE GLYCOLSFOR USE IN THE MANUFACTURE OF THERAPEUTIC AND DIAGNOSTIC AGENTS AND AS IMAGING AGENTS FOR DIAGNOSTIC PURPOSES; LIPOSOMES, PROTEINS AND PEPTIDES FOR USE IN THE MANUFACTURE OF PHARMACEUTICALS; DIAGNOSTIC AGENTS AND REAGENTS FOR MEDICAL RESEARCH USE; POLYMER MODIFIED COMPOUNDS FOR USE IN THE MANUFACTURE OF THERAPEUTIC AND DIAGNOSTIC AGENTS; IMAGING AGENTS FOR DIAGNOSTIC PURPOSES

3 COSMETIC AND TOILETRY PRODUCTS CONTAINING POLYMER1~-DERIVATIVES; NAMELY, EAU DE COLOGNE, PERFUMES, SHAVING SOAP, TALCUM POWDER, DENTIFRICES, TOOTHPASTE, ESSENTIAL OILS FOR PERSONAL USE, BATH OILS AND BATH SALTS,DEODORANTS FOR PERSONAL USE, SOAPS, SKIN CREAMS AND SKIN LOTIONS, MOISTURIZING CREAMS, BODY LOTIONS, AFTERSHAVE, LIPSTICK, MASCARA, EYELINER, SKIN CLEANSERS,MAKE-UP POWDERS AND CREAMS; NAIL POLISH; HAIRCAREPRODUCTS, NAMELY, HAIR SHAMPOO, CONDITIONER AND GEL;HAIR COLORANTS AND HAIR SPRAYS; MOUSSES AND BALMS FOR HAIR STYLING AND HAIR CARE

5 PHARMACEUTICAL AND VETERINARY PREPARATIONS AND SUBSTANCES; NAMELY, PROTEINS, PEPTIDES, AMINO ACIDS AND THEIR DERIVATIVES, NAMELY, ANTIBODIES AND FRAGMENTS THEREOF; CYTOKINES AND DERIVATIVES OR FRAGMENTS THEREOF, NAMELY, THE INTERLEUKINS (IL), ESPECIALLY THE IL-IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-b AND IL-li SUBTYPES THEREOF; COLONY STIMULATING FACTORS, NAMELY,GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR,GRANULOCYTE-COLONY STIMULATING FACTOR (ALPHA AND BETA FORMS) AND MACROPHAGE-COLONY STIMULATING FACTOR (ALSO KNOWN AS CSF-1); HAEMOPOIETINS, NAMELY, ERYTHROPOIETIN,HAEMOPOIETIN-ALPHA AND KIT-LIGAND (ALSO KNOWN AS STEMCELL FACTOR OR STEEL FACTOR); INTERFERONS (IFNS), NAMELY,IFNALPHA, IFNBETA, IFNGAMMA; GROWTH FACTORS ANDBIFUNCTIONAL GROWTH MODULATORS, NAMELY, EPIDERMAL GROWTH FACTOR, PLATELET-DERIVED GROWTH FACTOR,TRANSFORMING GROWTH FACTOR (ALPHA AND BETA FORMS),AMPHIREGULIN, SOMATOMEDIN-C, BONE GROWTH FACTOR,FIBROBLAST GROWTH FACTORS, INSULIN-LIKE GROWTH FACTORS,HERAPIN BINDING GROWTH FACTORS AND TUMOR GROWTH FACTORS; DIFFERENTIATION FACTORS AND THE LIKE, NAMELY,MACROPHAGE DIFFERENTIATING FACTOR, DIFFERENTIATION INDUCING FACTOR (DIF) AND LEUKEMIA INHIBITORY FACTOR;ACTIVATING FACTORS, NAMELY, PLATELET ACTIVATING FACTOR;COAGULATION FACTORS SUCH AS FIBRINOLYTIC/ANTICOAGULANT AGENTS INCLUDING HERAPIN AND PROTEASES AND THEIR PRO-FACTORS, NAMELY, CLOTTING FACTORS VII, VIII, IX, X, XI, XII, ANTITHROMBIN III, PROTEIN C, PROTEIN 5, STREPTOKINASE, UROKINASE, PROUROKINASE, TISSUE PLASMINOGEN ACTIVATOR, FIBRINOGEN AND HIRUDIN; PEPTIDE HORMONES, NAMELY, INSULIN AND CALCITONIN; ENZYMES, NAMELY, SUPEROXIDE DISMUTASE, GLUCOCEREBROSIDASE, ASPARAGINASE AND ADENOSINE DEAMINASE; TRANSCRIPTION FACTORS AND TRANSCRIPTIONAL MODULATORS; CARBOHYDRATES, GLYCOSOAMINOGLYCANS, GLYCOPROTEINS AND POLYSACCHARIDES; LIPIDS, NAMELY, PHOSPHATIDYL-ETHANOLAMINE, PHOSPHATIDYLSERINE AND DERIVATIVES THEREOF; SPHINGOSINE; STEROIDS, NAMELY, CHOLESTEROL AND DERIVATIVES THEREOF; NUCLEOTIDES, NUCLEOSIDES, HETEROCYCLIC BASES, DNA, RNA, SYNTHETIC AND NON-SYNTHETIC OLIGONUCLEOTIDES INCLUDING THOSE WITH NUCLEASE RESISTANT BACKBONES; VITAMINS; ANTIBIOTICS; BACTERISTATIC AND BACTERICIDAL AGENTS; ANTIFUNGAL, ANTHELMINTHIC AND OTHER AGENTS EFFECTIVE AGAINST INFECTIVE AGENTS INCLUDING UNICELLULAR PATHOGENS; SMALL EFFECTOR MOLECULES, NAMELY, NORADRENALIN, ALPHA ADRENERGIC RECEPTOR LIGANDS, DOPAMINE RECEPTOR LIGANDS, HISTAMINE RECEPTOR LIGANDS, GABAIBENZODIAZEPINE RECEPTOR LIGANDS, SEROTONIC RECEPTOR LIGANDS, LEUKOTRIENES AND TRIIODOTHYRONINE; CYTOTOXIC AGENTS SUCH AS DOXORUBICIN, METHOTREXATE AND DERIVATIVES THEREOF; VACCINES, NAMELY, HEPATITIS-B VACCINE, MALARIA VACCINE, MELANOMA VACCINE AND HIV-1 VACCINE

10 CATHETERS; STENTS AND PARTS AND FITTINGS FOR THESE GOODS

42 RESEARCH AND CONSULTANCY SERVICES RELATING TO PHARMACEUTICALS, VETERINARY PRODUCTS, SANITARY PRODUCTS, GENE THERAPY, CANCER TREATMENT AND POLYMERTECHNOLOGY IN MEDICINE; LICENSING OF INTELLECTUAL PROPERTY, NAMELY, TECHNOLOGY LICENSING SERVICES RELATING TO PHARMACEUTICALS, VETERINARY PRODUCTS, SANITARY PRODUCTS, GENE THERAPY, CANCER TREATMENT AND POLYMER TECHNOLOGY

COMBINATION MASC

Trademark Events

Mar 9, 2003

Abandonment - Failure To Respond Or Late Response

Jul 16, 2002

Inquiry As To Suspension Mailed

May 18, 2001

Letter Of Suspension Mailed

Jan 17, 2001

Correspondence Received In Law Office

Jul 17, 2000

Non-Final Action Mailed

Jul 3, 2000

Assigned To Examiner

Jun 28, 2000

Assigned To Examiner